PDF herunterladen
CC BY 4.0 · Journal of Child Science 2020; 10(01): e25-e31
DOI: 10.1055/s-0040-1713362
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Diagnostic Value of Different Biomarkers to Identify Bacterial Coinfection in Vietnamese Children with Severe Rhinovirus Pneumonia

Hien Thu Pham
1   Department of International Outpatient, National Children's Hospital, Hanoi, Vietnam
,
Tran Thi Ngoc Nguyen
2   Respiratory Center, National Children's Hospital, Hanoi, Vietnam
,
Ngo Thi Tam 
3   Faculty of Health Sciences, Thang Long University, Hanoi, Vietnam
› Institutsangaben
Weitere Informationen

Publikationsverlauf

09. März 2020

08. Mai 2020

Publikationsdatum:
17. Juni 2020 (online)

   Lizenzen und Reprints

Abstract

This study aims to assess the diagnostic value of high-sensitivity C-reactive protein (hs-CRP), procalcitonin (PCT), and interleukin (IL)-6 in the diagnosis of pneumonia caused by Rhinovirus alone or with bacterial coinfection in Vietnamese children under 5 years of age. A cross-sectional study was conducted on 26 children under 5 years of age with severe pneumonia due to Rhinovirus at the National Pediatric Hospital. IL-6, hs-CRP, and PCT tests were performed. The diagnostic values of PCT, IL-6, and hs-CRP in classifying those with viral alone and those with bacterial coinfection were determined. Of 26 children, 10 children were diagnosed to have bacterial coinfections (38.5%). The optimal cutoff point for PCT was > 2.30 ng/mL (sensitivity 50%, specificity 94%, positive predictive value 83%, and negative predictive value 75%). The optimal cutoff point for hs-CRP was > 1.53 mg/dl (sensitivity 90%, specificity 56%, positive predictive value 56%, and negative predictive value 90%). Finally, the optimal cut-off point for IL-6 was > 441.5 pg/mL (sensitivity 20%, specificity 100%, positive predictive value 100%, and negative predictive value 60%). The accuracy rate of PCT was the highest with 69.2%, followed by hs-CRP with 65.4%. Inflammatory biomarkers such as PCT and hs-CRP were able to distinguish children with severe pneumonia caused by Rhinovirus alone and those with bacterial coinfection.

Keywords

respiratory syncytial virus - pneumonia - procalcitonin - bacterial coinfections
 

  • References

  • 1 Jartti T, Lehtinen P, Vuorinen T, Ruuskanen O. Bronchiolitis: age and previous wheezing episodes are linked to viral etiology and atopic characteristics. Pediatr Infect Dis J 2009; 28 (04) 311-317
    CrossrefPubMedGoogle Scholar
  • 2 Bhuyan GS, Hossain MA, Sarker SK. , et al. Bacterial and viral pathogen spectra of acute respiratory infections in under-5 children in hospital settings in Dhaka city. PLoS One 2017; 12 (03) e0174488-e0174488
    CrossrefPubMedGoogle Scholar
  • 3 Müller L, Mack I, Tapparel C. , et al. Human rhinovirus types and association with respiratory symptoms during the first year of life. Pediatr Infect Dis J 2015; 34 (08) 907-909
    CrossrefPubMedGoogle Scholar
  • 4 Byington CL, Ampofo K, Stockmann C. , et al. Community surveillance of respiratory viruses among families in the Utah Better Identification of Germs-Longitudinal Viral Epidemiology (BIG-LoVE) Study. Clin Infect Dis 2015; 61 (08) 1217-1224
    CrossrefPubMedGoogle Scholar
  • 5 Schilder AGM, Chonmaitree T, Cripps AW. , et al. Otitis media. Nat Rev Dis Primers 2016; 2 (01) 16063-16063
    CrossrefPubMedGoogle Scholar
  • 6 Meissner HC. Viral bronchiolitis in children. N Engl J Med 2016; 374 (01) 62-72
    CrossrefPubMedGoogle Scholar
  • 7 Jacobs SE, Lamson DM, St George K, Walsh TJ. Human rhinoviruses. Clin Microbiol Rev 2013; 26 (01) 135-162
    CrossrefPubMedGoogle Scholar
  • 8 Hai T, Bich VTN, Ngai K. , et al. Fatal respiratory infections associated with rhinovirus outbreak, Vietnam. Emerg Infect Dis 2012; 18 (11) 1886-1888
    CrossrefPubMedGoogle Scholar
  • 9 Iwane MK, Prill MM, Lu X. , et al. Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis 2011; 204 (11) 1702-1710
    CrossrefPubMedGoogle Scholar
  • 10 Toivonen L, Schuez-Havupalo L, Karppinen S. , et al. Disease burden caused by rhinovirus infections during the first two years of life. Open Forum Infect Dis 2015; 2 (01) 517
    CrossrefPubMedGoogle Scholar
  • 11 Fine J, Bray-Aschenbrenner A, Williams H, Buchanan P, Werner J. The resource burden of infections with rhinovirus/enterovirus, influenza, and respiratory syncytial virus in children. Clin Pediatr (Phila) 2019; 58 (02) 177-184
    CrossrefPubMedGoogle Scholar
  • 12 MacBean V, Drysdale SB, Yarzi MN, Peacock JL, Rafferty GF, Greenough A. Respiratory viral infections in infancy and school age respiratory outcomes and healthcare costs. Pediatr Pulmonol 2018; 53 (03) 342-348
    CrossrefPubMedGoogle Scholar
  • 13 Jung HS, Kang BJ, Ra SW. , et al. Elucidation of bacterial pneumonia-causing pathogens in patients with respiratory viral infection. Tuberc Respir Dis (Seoul) 2017; 80 (04) 358-367
    CrossrefPubMedGoogle Scholar
  • 14 Wark PA, Tooze M, Powell H, Parsons K. Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission. Respirology 2013; 18 (06) 996-1002
    CrossrefPubMedGoogle Scholar
  • 15 Van-Tam J., Sellwood C. Pandemic Influenza. CABI, 2nd ed, 2012. (Chap 1): 1–8
    PubMed
  • 16 Rodrigues CMC, Groves H. Community-Acquired Pneumonia in Children: the Challenges of Microbiological Diagnosis. J Clin Microbiol 2018; 56 (03) e01318-17
    PubMedGoogle Scholar
  • 17 Klig JE. Office pediatrics: current perspectives on the outpatient evaluation and management of lower respiratory infections in children. Curr Opin Pediatr 2006; 18 (01) 71-76
    CrossrefPubMedGoogle Scholar
  • 18 Thomas J, Pociute A, Kevalas R, Malinauskas M, Jankauskaite L. Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review. Ital J Pediatr 2020; 46 (01) 4-4
    CrossrefPubMedGoogle Scholar
  • 19 Harris M, Clark J, Coote N. , et al; British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 2011; 66 (Suppl. 02) ii1-ii23
    CrossrefPubMedGoogle Scholar
  • 20 Esposito S, Di Gangi M, Cardinale F. , et al; Ita-CAP Study Group. Sensitivity and specificity of soluble triggering receptor expressed on myeloid cells-1, midregional proatrial natriuretic peptide and midregional proadrenomedullin for distinguishing etiology and to assess severity in community-acquired pneumonia. PLoS One 2016; 11 (11) e0163262-e0163262
    CrossrefPubMedGoogle Scholar
  • 21 Naydenova E, Tsanas A, Howie S, Casals-Pascual C, De Vos M. The power of data mining in diagnosis of childhood pneumonia. J R Soc Interface 2016; 13 (120) 20160266
    CrossrefPubMedGoogle Scholar
  • 22 Zhu F, Jiang Z, Li WH, Wei HY, Su GD. Clinical significance of serum procalcitonin level monitoring on early diagnosis of severe pneumonia on children. Eur Rev Med Pharmacol Sci 2015; 19 (22) 4300-4303
    PubMedGoogle Scholar
  • 23 Baumann P, Baer G, Bonhoeffer J. , et al. Procalcitonin for diagnostics and treatment decisions in pediatric lower respiratory tract infections. Front Pediatr 2017; 5: 183-183
    CrossrefPubMedGoogle Scholar
  • 24 Ho NT, Thompson C, Nhan LNT. , et al. Retrospective analysis assessing the spatial and temporal distribution of paediatric acute respiratory tract infections in Ho Chi Minh City, Vietnam. BMJ Open 2018; 8 (01) e016349
    CrossrefPubMedGoogle Scholar
  • 25 World Health Organization, Guidelines for The Management of Common Childhood Illnesses. World Health Organization, Pham Ngoc Thach’s University of Medicine. 2nd ed. 2013
  • 26 Hartiala M, Lahti E, Forsström V, Vuorinen T, Ruuskanen O, Peltola V. Characteristics of hospitalized rhinovirus-associated community-acquired pneumonia in children, Finland, 2003-2014. Front Med (Lausanne) 2019; 6: 235-235
    CrossrefPubMedGoogle Scholar
  • 27 Rambaud-Althaus C, Althaus F, Genton B, D'Acremont V. Clinical features for diagnosis of pneumonia in children younger than 5 years: a systematic review and meta-analysis. Lancet Infect Dis 2015; 15 (04) 439-450
    PubMedGoogle Scholar
  • 28 Thompson M, Coad N, Harnden A, Mayon-White R, Perera R, Mant D. How well do vital signs identify children with serious infections in paediatric emergency care?. Arch Dis Child 2009; 94 (11) 888-893
    CrossrefPubMedGoogle Scholar
  • 29 Salah ET, Ahmed E, Elhussien M, Salah T. The use of vital signs as predictors for serious bacterial infections in children with acute febrile illness in a pediatric emergency setting in Sudan. Sudan J Paediatr 2014; 14 (02) 35-40
    PubMedGoogle Scholar
  • 30 Gou X, Yuan J, Wang H. , et al. IL-6 during influenza-Streptococcus pneumoniae co-infected pneumonia-A protector. Front Immunol 2020; 10: 3102-3102
    CrossrefPubMedGoogle Scholar
  • 31 Karhu J, Ala-Kokko TI, Vuorinen T, Ohtonen P, Julkunen I, Syrjälä HT. Interleukin-5, interleukin-6, interferon induced protein-10, procalcitonin and C-reactive protein among mechanically ventilated severe community-acquired viral and bacterial pneumonia patients. Cytokine 2019; 113: 272-276
    CrossrefPubMedGoogle Scholar
  • 32 Esposito S, Bianchini S, Gambino M. , et al. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia. BMC Pulm Med 2016; 16 (01) 103-103
    CrossrefPubMedGoogle Scholar
  • 33 Bhuiyan MU, Blyth CC, West R. , et al. Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children. BMC Pulm Med 2019; 19 (01) 71-71
    CrossrefPubMedGoogle Scholar
  • 34 Xu RY, Liu HW, Liu JL, Dong JH. Procalcitonin and C-reactive protein in urinary tract infection diagnosis. BMC Urol 2014; 14: 45
    CrossrefPubMedGoogle Scholar
  • 35 Zhou WF, Chen Q, Jin MF. , et al. The diagnostic accuracy of high-mobility group box 1 protein and twelve other markers in discriminating bacterial, viral and co-infected bronchial pneumonia in Han children. Microbiol Immunol 2011; 55 (04) 279-288
    CrossrefPubMedGoogle Scholar
  • 36 Elemraid MA, Rushton SP, Thomas MF, Spencer DA, Gennery AR, Clark JE. Utility of inflammatory markers in predicting the aetiology of pneumonia in children. Diagn Microbiol Infect Dis 2014; 79 (04) 458-462
    CrossrefPubMedGoogle Scholar
  • 37 Berg AS, Inchley CS, Fjaerli HO, Leegaard TM, Lindbaek M, Nakstad B. Clinical features and inflammatory markers in pediatric pneumonia: a prospective study. Eur J Pediatr 2017; 176 (05) 629-638
    CrossrefPubMedGoogle Scholar
  • 38 Virkki R, Juven T, Rikalainen H, Svedström E, Mertsola J, Ruuskanen O. Differentiation of bacterial and viral pneumonia in children. Thorax 2002; 57 (05) 438-441
    CrossrefPubMedGoogle Scholar
  • 39 Jin M, Khan AI. Procalcitonin: uses in the clinical laboratory for the diagnosis of sepsis. Lab Med 2010; 41 (03) 173-177
    CrossrefPubMedGoogle Scholar
  • 40 Hoshina T, Nanishi E, Kanno S, Nishio H, Kusuhara K, Hara T. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis. J Infect Chemother 2014; 20 (10) 616-620
    CrossrefPubMedGoogle Scholar
  • 41 Lacour AG, Gervaix A, Zamora SA. , et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur J Pediatr 2001; 160 (02) 95-100
    CrossrefPubMedGoogle Scholar
  • 42 Moulin F, Raymond J, Lorrot M. , et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child 2001; 84 (04) 332-336
    CrossrefPubMedGoogle Scholar
  • 43 Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39 (02) 206-217
    CrossrefPubMedGoogle Scholar
  • 44 Moulin F, Raymond J, Lorrot M. , et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child 2001; 84 (04) 332-336
    CrossrefPubMedGoogle Scholar
  • 45 Boussekey N, Leroy O, Alfandari S, Devos P, Georges H, Guery B. Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia. Intensive Care Med 2006; 32 (03) 469-472
    CrossrefPubMedGoogle Scholar
  • 46 Christ-Crain M, Stolz D, Bingisser R. , et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006; 174 (01) 84-93
    CrossrefPubMedGoogle Scholar